Maravai LifeSciences Holdings Inc. announced that Benjamin Daverman, Jessica Hopfield, PhD, and Murali Prahalad, PhD have resigned from the Board of Directors, reducing the board size from eleven to eight members. R. Andrew Eckert was appointed chair of the Nominating, Governance and Risk Committee and as a member of the Audit Committee, while Gregory T. Lucier was appointed to the Nominating, Governance and Risk Committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maravai LifeSciences Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001823239-25-000113), on October 27, 2025, and is solely responsible for the information contained therein.
Comments